AstraZeneca will buy U.S.-based CinCor for cardiorenal asset
January 09, 2023 at 02:29 AM EST
The Anglo-Swedish pharma giant said that it will initiate a tender offer to acquire all of U.S.-listed clinical-stage biopharmaceutical company CinCor's CINC outstanding shares.
